Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 4
2000 1
2001 1
2004 3
2005 2
2006 3
2008 7
2009 13
2010 8
2011 8
2012 8
2013 4
2014 1
2015 5
2016 8
2017 6
2018 2
2019 5
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic T cell engineering.
Sadelain M, Rivière I, Riddell S. Sadelain M, et al. Nature. 2017 May 24;545(7655):423-431. doi: 10.1038/nature22395. Nature. 2017. PMID: 28541315 Free PMC article. Review.
The basic principles of chimeric antigen receptor design.
Sadelain M, Brentjens R, Rivière I. Sadelain M, et al. Cancer Discov. 2013 Apr;3(4):388-98. doi: 10.1158/2159-8290.CD-12-0548. Epub 2013 Apr 2. Cancer Discov. 2013. PMID: 23550147 Free PMC article. Review.
Driving CAR T-cells forward.
Jackson HJ, Rafiq S, Brentjens RJ. Jackson HJ, et al. Nat Rev Clin Oncol. 2016 Jun;13(6):370-83. doi: 10.1038/nrclinonc.2016.36. Epub 2016 Mar 22. Nat Rev Clin Oncol. 2016. PMID: 27000958 Free PMC article. Review.
GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells.
Smith EL, Harrington K, Staehr M, Masakayan R, Jones J, Long TJ, Ng KY, Ghoddusi M, Purdon TJ, Wang X, Do T, Pham MT, Brown JM, De Larrea CF, Olson E, Peguero E, Wang P, Liu H, Xu Y, Garrett-Thomson SC, Almo SC, Wendel HG, Riviere I, Liu C, Sather B, Brentjens RJ. Smith EL, et al. Sci Transl Med. 2019 Mar 27;11(485):eaau7746. doi: 10.1126/scitranslmed.aau7746. Sci Transl Med. 2019. PMID: 30918115 Free PMC article.
Novel immunotherapies in lymphoid malignancies.
Batlevi CL, Matsuki E, Brentjens RJ, Younes A. Batlevi CL, et al. Nat Rev Clin Oncol. 2016 Jan;13(1):25-40. doi: 10.1038/nrclinonc.2015.187. Epub 2015 Nov 3. Nat Rev Clin Oncol. 2016. PMID: 26525683 Free PMC article. Review.
Hematopoietic stem cell engineering at a crossroads.
Rivière I, Dunbar CE, Sadelain M. Rivière I, et al. Blood. 2012 Feb 2;119(5):1107-16. doi: 10.1182/blood-2011-09-349993. Epub 2011 Nov 17. Blood. 2012. PMID: 22096239 Free PMC article. Review.
Modulation of GITR for cancer immunotherapy.
Schaer DA, Murphy JT, Wolchok JD. Schaer DA, et al. Curr Opin Immunol. 2012 Apr;24(2):217-24. doi: 10.1016/j.coi.2011.12.011. Epub 2012 Jan 12. Curr Opin Immunol. 2012. PMID: 22245556 Free PMC article. Review.
Adoptive T-Cell Therapy for Solid Tumors.
Yeku O, Li X, Brentjens RJ. Yeku O, et al. Am Soc Clin Oncol Educ Book. 2017;37:193-204. doi: 10.1200/EDBK_180328. Am Soc Clin Oncol Educ Book. 2017. PMID: 28561728 Free PMC article.
84 results